Atlas Trials

Pharmacokinetic and Pharmacodynamic Study of Bardoxolone Methyl in Patients With Chronic Kidney Disease and Type 2 Diabetes

Clinical trial NCT01549769 · TERMINATED

Trial details

NCT number
NCT01549769
Sponsor
Biogen
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Renal Insufficiency, ChronicDiabetes Mellitus, Type 2
Start date
2012-04-30
Primary completion
2012-11-30
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.